The Financial Comet
  • Business
  • World News
  • Politics
  • Investing
  • Business
  • World News
  • Politics
  • Investing

The Financial Comet

Investing

Acceleration of RAD204 Phase 1 dose escalation trial

by admin May 12, 2025
May 12, 2025
Acceleration of RAD204 Phase 1 dose escalation trial

Radiopharm Theranostics (RAD:AU) has announced Acceleration of RAD204 Phase 1 dose escalation trial

Download the PDF here.

This post appeared first on investingnews.com

previous post
Multiple New Multi-Commodity Targets
next post
Excellent Gold Intersections Verified at Kiimala Project

Related Posts

Silver Crown Royalties Announces Annual General Meeting Results

June 25, 2025

Stallion Uranium Announces Flow-Through and Non-Flow Through Private...

August 6, 2025

Cleantech Market Update: Q3 2025 in Review

October 21, 2025

Results of General Meeting, Admission of Retail Offer...

March 25, 2025

Over 50% Q-o-Q Production Growth Targeted

September 16, 2025

Sankamap Updates Status on Late Filing of Financial...

December 4, 2025

Prospectus

June 20, 2025

Maiden Underground Ore Reserves Underpins FY26 Production

June 26, 2025

After US$1.5 Billion Gold Payday, Chinese Billionaire Pivots...

May 22, 2025

Keith Weiner: All Roads Lead to Gold Right...

March 27, 2025

    Join our mailing list to get access to special deals, promotions, and insider information. Your exclusive benefits await! Enjoy personalized recommendations, first dibs on sales, and members-only content that makes you feel like a true VIP. Sign up now and start saving!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Editors’ Picks

    • 1

      DeepSeek hit with large-scale cyberattack, says it’s limiting registrations

      January 28, 2025
    • 2

      Trump re-designates Iranian-backed Houthis as terrorists: ‘Threaten[s] security of American civilians’

      January 23, 2025
    • 3

      Universal’s ‘Wicked: For Good’ creates a unique marketing challenge

      January 27, 2025
    • 4

      UnitedHealthcare taps company veteran Tim Noel as new CEO following Brian Thompson killing

      January 27, 2025
    • 5

      Bank of America CEO says financial industry will jump into crypto payments if regulators allow it

      January 23, 2025
    • 6

      FDA officially authorizes Zyn nicotine pouches for sale following health review

      January 23, 2025
    • 7

      Lara Trump to host weekend show on Fox News

      February 7, 2025
    • About us
    • Contacts
    • Privacy Policy
    • Terms and Conditions
    • Email Whitelisting

    Disclaimer: thefinancialcomet.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2025 thefinancialcomet.com | All Rights Reserved